Sign inJoin waitlistJoin the waitlist

EG

Eric Grewal

Pathology / Clinical Pathology/Laboratory Medicine

Credentials: · · ·

History

Pathology
Massachusetts General Hospital
2022–2025
Mayo Clinic College of Medicine and Science
2018–2022

Research

Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Nature Communications · 2024 · 28 citations
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma
Clinical Cancer Research · 2024 · Co-first of 10 authors · 9 citations
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial
Journal for ImmunoTherapy of Cancer · 2025 · 9 citations

Bryan Choi
9 papers
William Curry
9 papers
Rishab Ramapriyan
7 papers · 4 as a resident
Maria Martinez-Lage
4 papers
Bob Carter
3 papers
Brian Nahed
3 papers
Daniel Cahill
3 papers
EG
Elizabeth Gerstner
3 papers
Julie Miller
3 papers
Lisa Kottschade
3 papers
Matthew Block
3 papers
MR
Maxwell Roth
3 papers · 3 as a resident